Steven Cohen Akouos, Inc. Transaction History

Point72 Asset Management, L.P.

  • $39.3 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$2.6 - $5.16 $287,765 - $571,103
110,679 New
110,679 $748,000
Q3 2020

Nov 16, 2020
SELL
$19.3 - $26.92 $125,450 - $174,980
-6,500 Closed
0 $0
Q2 2020

Aug 14, 2020
BUY
$22.0 - $22.5 $143,000 - $146,250
6,500 New
6,500 $146,000

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track Steven Cohen's Portfolio

Track Steven Cohen Portfolio

Follow Steven Cohen (Point72 Asset Management, L.P.) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email